The classification of uncertain histologies based on cfDNA fragmentomic analysis in patients with uncommon cancers screened for NCI-MATCH.
Chris Karlovich(Clovis Oncology (United States)), James H. Doroshow(National Cancer Institute), Peter J. O’Dwyer(University of Pennsylvania), Rini Pauly(Frederick National Laboratory for Cancer Research), Jennifer S. LoCoco(Illumina (United States)), Traci Pawlowski(Illumina (United States)), Lisa M. McShane(National Cancer Institute), Peter Wu(Leidos (United States)), Vishnuprabha Rahul Kannan(Frederick National Laboratory for Cancer Research), Alice P. Chen(National Institutes of Health), Biswajit Das(Frederick National Laboratory for Cancer Research), Stanley R. Hamilton(City of Hope), Bao T. Le(University of Wisconsin–Madison), Eric Greenbank(Frederick National Laboratory for Cancer Research), Li Chen(Harvard University), Lyndsay N. Harris(National Institutes of Health), Amanda Peach(Frederick National Laboratory for Cancer Research), Keith T. Flaherty(Cancer Research Center)
Cited by 0
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k